Skip to main content
Clinical Trials/NL-OMON22564
NL-OMON22564
Completed
Not Applicable

A prospective, web-based, patient-centered, interactive study of long-term disabilities, disability perception and health-related quality of life in patients with multiple sclerosis (MS) and clinically isolated syndrome in the Netherlands.

ationaal MS Fonds Industrieweg 130C 3044 AT Rotterdam 010 – 591 98 39 info@nationaalmsfonds.nl Curavista bv Markt 9 4931 BR Geertruidenberg Tel: 0162 520 964 info@curavista.nl MS4 Research Institute Dr. Peter Joseph (Sjef) Jongen Ubbergseweg 34 6522 KJ Nijmegen The Netherlands0 sites500 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple sclerosis
Sponsor
ationaal MS Fonds Industrieweg 130C 3044 AT Rotterdam 010 – 591 98 39 info@nationaalmsfonds.nl Curavista bv Markt 9 4931 BR Geertruidenberg Tel: 0162 520 964 info@curavista.nl MS4 Research Institute Dr. Peter Joseph (Sjef) Jongen Ubbergseweg 34 6522 KJ Nijmegen The Netherlands
Enrollment
500
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
ationaal MS Fonds Industrieweg 130C 3044 AT Rotterdam 010 – 591 98 39 info@nationaalmsfonds.nl Curavista bv Markt 9 4931 BR Geertruidenberg Tel: 0162 520 964 info@curavista.nl MS4 Research Institute Dr. Peter Joseph (Sjef) Jongen Ubbergseweg 34 6522 KJ Nijmegen The Netherlands

Eligibility Criteria

Inclusion Criteria

  • 1\) Diagnosis of MS or Clinically Isolated Syndrome (CIS)
  • 2\) Willing and able to comply with the study protocol
  • 3\) Having access to the internet
  • 4\) Have given informed consent

Exclusion Criteria

  • Not defined

Outcomes

Primary Outcomes

Not specified

Similar Trials